Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1990 | 03-1990 | 12-1989 | 09-1989 | 06-1989 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 7,815 | -351 | 17,013 | 7,018 | 9,353 |
| TOTAL | $7,815 | $-351 | $17,013 | $7,018 | $9,353 |
| Non-Current Assets | |||||
| PPE Net | 433,882 | 425,761 | 420,976 | 410,251 | 391,563 |
| Investments And Advances | 2,986 | 3,097 | 3,201 | 0 | 0 |
| Other Non-Current Assets | 10,060 | 20,887 | 9,301 | 10,368 | 9,349 |
| TOTAL | $446,928 | $449,745 | $433,478 | $420,619 | $400,912 |
| Total Assets | $454,743 | $449,394 | $450,491 | $427,637 | $410,265 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22,884 | 8,460 | 31,503 | 18,030 | 29,130 |
| Accounts payable and accrued liabilities | 13,782 | 15,844 | 22,904 | 17,398 | 14,969 |
| Accrued Expenses | 4,346 | 16,350 | 5,952 | 4,948 | 3,521 |
| TOTAL | $69,896 | $62,753 | $90,721 | $54,047 | $72,640 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 17,343 | 0 | 17,373 |
| TOTAL | $55,979 | $55,202 | $53,803 | $52,765 | $51,917 |
| Total Liabilities | $125,875 | $117,955 | $144,524 | $106,812 | $124,557 |
| Shareholders' Equity | |||||
| Common Shares | 116,339 | 119,051 | 27,132 | 112,168 | 115,300 |
| TOTAL | $116,339 | $119,051 | $35,606 | $112,168 | $115,300 |
| Total Liabilities And Equity | $242,214 | $237,006 | $180,130 | $218,980 | $239,857 |